Similar Articles
1121 Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: Propensity score analysis
1122 Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma
1123 Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectives
1124 Hepatitis D and hepatocellular carcinoma
1125 Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
1126 Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question
1127 Preparation of magnetic resonance probes using one-pot method for detection of hepatocellular carcinoma
1128 Polymorphisms of glutathione S-transferase genes and survival of resected hepatocellular carcinoma patients
1129 Clostridium perfringens infection after transarterial chemoembolization for large hepatocellular carcinoma
1130 Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA